28 May 2009

SEDATIVE/HYPNOTICS ANXIOLYTICS



SEDATIVE/HYPNOTICS ANXIOLYTICS
By:Martha I. Dávila-García, Ph.D.
Department of Pharmacology, Howard University

Optimal Performance Nervous Breakdown
Performance Anxiety GOAL
SEDATIVE/HYPNOTICS ANXIOLYTICS
Manifestations of anxiety:
Pathological Anxiety
Causes of Anxiety
1). Medical:
o Respiratory
o Endocrine
o Cardiovascular
o Metabolic
o Neurologic.

2). Drug-Induced:
o Stimulants
+ Amphetamines, cocaine, TCAs, caffeine.
o Sympathomimetics
+ Ephedrine, epinephrine, pseudoephedrine phenylpropanolamine.
o Anticholinergics\Antihistaminergics
+ Trihexyphenidyl, benztropine, meperidine diphenhydramine, oxybutinin.
o Dopaminergics
+ Amantadine, bromocriptine, L-Dopa, carbid/levodopa.
o Miscellaneous:
+ Baclofen, cycloserine, hallucinogens, indomethacin.

3). Drug Withdrawal:
Anxiolytics
Sedative/Hypnotics
Properties of Sedative/Hypnotics in Sleep
1) The latency of sleep onset is decreased (time to fall asleep).
2) The duration of stage 2 NREM sleep is increased.
3) The duration of REM sleep is decreased.
4) The duration of slow-wave sleep (when somnambulism and nightmares occur) is decreased.
Other Properties of Sedative/Hypnotics
GABAergic SYSTEM
Benzodiazepines
* Diazepam
* Triazolam
* Lorazepam
* Alprazolam
* Clorazepate => nordiazepam
* Halazepam
* Clonazepam
* Oxazepam
* Prazepam
Barbiturates
* Phenobarbital
* Pentobarbital
* Amobarbital
* Mephobarbital
* Secobarbital
* Aprobarbital
Respiratory Depression
Coma/Anesthesia
Ataxia
Sedation
Anxiolytic
Anticonvulsant
DOSE
RESPONSE
BARBS
BDZs
ETOH
GABAergic SYNAPSE
GABA
glutamate
glucose
GAD
GABA-A Receptor
GABA AGONISTS BDZs
Mechanisms of Action
Benzodiazepines
PHARMACOLOGY
* BDZs potentiate GABAergic inhibition at all levels of the neuraxis.
* BDZs cause more frequent openings of the GABA-Cl- channel via membrane hyperpolarization, and increased receptor affinity for GABA.
* BDZs act on BZ1 (1 and 2 subunit-containing) and BZ2 (5 subunit-containing) receptors.
* May cause euphoria, impaired judgement, loss of cell control and anterograde amnesic effects.

Pharmacokinetics of Benzodiazepines
CNS Effects
Lipid solubility
Biotransformation of Benzodiazepines
Properties of Benzodiazepines
Side Effects of Benzodiazepines
Toxicity/Overdose with Benzodiazepines
Drug-Drug Interactions with BDZs
Pharmacokinetics of Barbiturates
Properties of Barbiturates Mechanism of Action.
Toxicity/Overdose
Miscellaneous Drugs
* Buspirone
* Chloral hydrate
* Hydroxyzine
* Meprobamate (Similar to BARBS)
* Zolpidem (BZ1 selective)
* Zaleplon (BZ1 selective)
Properties of Other drugs.
OTHER USES
ANXYOLITICS
Alprazolam
Chlordiazepoxide
Buspirone
Diazepam
Lorazepam
Oxazepam
Triazolam
Phenobarbital
Halazepam
Prazepam
HYPNOTICS
Chloral hydrate
Estazolam
Flurazepam
Pentobarbital
Lorazepam
Quazepam
Triazolam
Secobarbital
Temazepam
Zolpidem
References:

SEDATIVE/HYPNOTICS ANXIOLYTICS.ppt

Read more...

ANTIEPILEPTIC DRUGS



ANTIEPILEPTIC DRUGS
By:Martha I. Dávila-García, Ph.D.
Department of Pharmacology, Howard University

Epilepsy

A group of chronic CNS disorders characterized by recurrent seizures.
* Seizures are sudden, transitory, and uncontrolled episodes of brain dysfunction resulting from abnormal discharge of neuronal cells with associated motor, sensory or behavioral changes.

Causes for Acute Seizures
* Trauma
* Encephalitis
* Drugs
* Birth trauma
* Withdrawal from depressants
* Tumor
* High fever
* Hypoglycemia
* Extreme acidosis
* Extreme alkalosis Hyponatremia
* Hypocalcemia
* Idiopathic
Seizures
* The causes for seizures can be multiple, from infection, to neoplasms, to head injury. In a few subgroups it is an inherited disorder.
* Febrile seizures or seizures caused by meningitis are treated by antiepileptic drugs, although they are not considered epilepsy (unless they develop into chronic seizures).
* Seizures may also be caused by acute underlying toxic or metabolic disorders, in which case the therapy should be directed towards the specific abnormality.

Neuronal Substrates of Epilepsy
The Brain
The Synapse
The Ion Channels/Receptors
ions
Cellular and Synaptic Mechanisms of Epileptic Seizures
I. Partial (focal) Seizures
II. Generalized Seizures


Classification of Epileptic Seizures
Scheme of Seizure Spread
Simple (Focal) Partial
Contralateral spread
I. Partial (Focal) Seizures
Scheme of Seizure Spread
Complex Partial Seizures
Complex Secondarily Generalized Partial Seizures

I. Partial (focal) Seizures
II. Generalized Seizures
* Generalized Tonic-Clonic Seizures
* Absence Seizures
* Tonic Seizures
* Atonic Seizures
* Clonic and Myoclonic Seizures.
* Infantile Spasms

II. Generalized Seizures
Neuronal Correlates of Paroxysmal Discharges
B. Absence Seizures (Petite Mal)
Treatment of Seizures
Goals:
* Block repetitive neuronal firing.
* Block synchronization of neuronal discharges.
* Block propagation of seizure.
Strategies:
* Modification of ion conductances.
* Increase inhibitory (GABAergic) transmission.
* Decrease excitatory (glutamatergic) activity.

Actions of Phenytoin on Na+ Channels
* Resting State
* Arrival of Action Potential causes depolarization and channel opens allowing sodium to flow in.
* Refractory State, Inactivation
Sustain channel in this conformation
GABAergic SYNAPSE
Drugs that Act at the GABAergic Synapse
* GABA agonists
* GABA antagonists
* Barbiturates
* Benzodiazepines
* GABA synthesizing enzymes
* GABA uptake inhibitors
* GABA metabolizing enzymes
GLUTAMATERGIC SYNAPSE
* Excitatory Synapse.
* Permeable to Na+, Ca2+ and K+.
* Magnesium ions block channel in resting state.
* Glycine (GLY) binding enhances the ability of GLU or NMDA to open the channel.
* Agonists: NMDA, AMPA, Kianate.
Chemical Structure of Classical Antiseizure Agents
Treatment of Seizures
* Hydantoins: phenytoin
* Barbiturates: phenobarbital
* Oxazolidinediones: trimethadione
* Succinimides: ethosuximide
* Acetylureas: phenacemide
* Other: carbamazepine, lamotrigine, vigabatrin, etc.
* Diet
* Surgery, Vagus Nerve Stimulation (VNS).
* Most classical antiepileptic drugs exhibit similar pharmacokinetic properties.
* Good absorption (although most are sparingly soluble).
* Low plasma protein binding (except for phenytoin, BDZs, valproate, and tiagabine).
* Conversion to active metabolites (carbamazepine, primidone, fosphenytoin).
* Cleared by the liver but with low extraction ratios.
* Distributed in total body water.
* Plasma clearance is slow.
* At high concentrations phenytoin exhibits zero order kinetics.

Pharmacokinetic Parameters
Effects of three antiepileptic drugs on high frequency discharge of cultured neurons
Block of sustained high frequency repetitive firing of action potentials.
PHENYTOIN (Dilantin)
* Oldest nonsedative antiepileptic drug.
* Fosphenytoin, a more soluble prodrug is used for parenteral use.
* “Fetal hydantoin syndrome”.
* Manufacturers and preparations.
* It alters Na+, Ca2+ and K+ conductances.
* Inhibits high frequency repetitive firing.
* Alters membrane potentials.
* Alters a.a. concentration.
* Alters NTs (NE, ACh, GABA)
Toxicity:
* Ataxia and nystagmus.
* Cognitive impairment.
* Hirsutism
* Gingival hyperplasia.
* Coarsening of facial features.
* Dose-dependent zero order kinetics.
* Exacerbates absence seizures.
* At high concentrations it causes a type of decerebrate rigidity.
CARBAMAZEPINE (Tegretol)
* Tricyclic, antidepressant (bipolar)
* 3-D conformation similar to phenytoin.
* Mechanism of action, similar to phenytoin. Inhibits high frequency repetitive firing.
* Decreases synaptic activity presynaptically.
* Binds to adenosine receptors (?).
* Inh. uptake and release of NE, but not GABA.
* Potentiates postsynaptic effects of GABA.
* Metabolite is active.
Toxicity:
* Autoinduction of metabolism.
* Nausea and visual disturbances.
* Granulocyte supression.
* Aplastic anemia.
* Exacerbates absence seizures.
OXCARBAZEPINE (Trileptal)
* Closely related to carbamazepine.
* With improved toxicity profile.
* Less potent than carbamazepine.
* Active metabolite.
* Use in partial and generalized seizures as adjunct therapy.
* May aggravate myoclonic and absence seizures.
* Mechanism of action, similar to carbamazepine It alters Na+ conductance and inhibits high frequency repetitive firing.
Toxicity:
* Hyponatremia
* Less hypersensitivity and induction of hepatic enzymes than with carbamazepine
PHENOBARBITAL (Luminal)
* Except for the bromides, it is the oldest antiepileptic drug.
* Although considered one of the safest drugs, it has sedative effects.
* Many consider them the drugs of choice for seizures only in infants.
* Acid-base balance important.
* Useful for partial, generalized tonic-clonic seizures, and febrile seizures
* Prolongs opening of Cl- channels.
* Blocks excitatory GLU (AMPA) responses. Blocks Ca2+ currents (L,N).
* Inhibits high frequency, repetitive firing of neurons only at high concentrations.
Toxicity:
* Sedation.
* Cognitive impairment.
* Behavioral changes.
* Induction of liver enzymes.
* May worsen absence and atonic seizures.
PRIMIDONE (Mysolin)
* Metabolized to phenobarbital and phenylethylmalonamide (PEMA), both active metabolites.
* Effective against partial and generalized tonic-clonic seizures.
* Absorbed completely, low binding to plasma proteins.
* Should be started slowly to avoid sedation and GI problems.
* Its mechanism of action may be closer to phenytoin than the barbiturates.
Toxicity:
* Same as phenobarbital
* Sedation occurs early.
* Gastrointestinal complaints.
VALPROATE (Depakene)

ETHOSUXIMIDE (Zarontin)
CLONAZEPAM (Klonopin)
VIGABATRIN
LAMOTRIGINE (Lamictal)
FELBAMATE (Felbatrol)
TOPIRAMATE (Topamax)
TIAGABINE (Gabatril)
ZONISAMIDE (Zonegran)
GABAPENTIN (Neurontin)
Status Epilepticus
Treatment of Status Epilepticus in Adults
DIAZEPAM (Valium) AND
LORAZEPAM (Ativan)
Treatment of Seizures
PRIMARY GENERALIZED TONIC-CLONIC SEIZURES (Grand Mal)
GENERALIZED ABSENCE SEIZURES
ATYPICAL ABSENCE, MYOCLONIC, ATONIC* SEIZURES
INFANTILE SPASMS
Treatment of Seizures in Pregnancy
INTERACTIONS BETWEEN ANTISEIZURE DRUGS
ANTISEIZURE DRUG INTERACTIONS
With other drugs:

ANTIEPILEPTIC DRUGS.ppt
http://www.med.howard.edu/pharmacology/handouts/ANTIEPILEPTICS_OL2003.ppt

Read more...

Antiviral Agents



Antiviral Agents
By:Jillian H. Davis
Department of Pharmacology, Howard University

Viruses
* Obligate intracellular parasites
* Consist of a core genome in a protein shell and some are surrounded by a lipoprotein
* lack a cell wall and cell membrane
* do not carry out metabolic processes
* Replication depends on the host cell machinery
* Steps for Viral Replication

Sites of Drug Action
Antiviral Agents
Antiherpes Agents
* Acyclovir- prototype
* Valacyclovir
* Famciclovir
* Penciclovir
* Trifluridine
* Vidarabine
Mechanism of Action Acyclovir
* an acyclic guanosine derivative
* Phosphorylated by viral thymidine kinase
* Di-and tri-phosphorylated by host cellular enzymes
* Inhibits viral DNA synthesis
* Alteration in viral thymidine kinase
* Alteration in viral DNA polymerase
* Cross-resistance with valacyclovir, famciclovir, and ganciclovir

Clinical Uses Acyclovir
* Oral, IV, and Topical formulations
* Cleared by glomerular filtration and tubular secretion
* Uses:
o Herpes Simplex Virus 1 and 2 (HSV)
o Varicella-zoster virus (VZV)
* Side Effects: nausea, diarrhea, headache, tremors, and delirium

Valacyclovir
* L-valyl ester of acyclovir
* Converted to acyclovir when ingested
* M.O.A.: same as acyclovir
* Uses:
o 1) recurrent genital herpes
o 2) herpes zoster infections
* Side Effects: nausea, diarrhea, and headache

Famciclovir
* Prodrug of penciclovir (a guanosine analog)
* M.O.A.: same as acyclovir
* does not cause chain termination
* Uses: HSV-1, HSV-2, VZV, EBV, and hepatitis B
* Side Effects: nausea, diarrhea, and headache

Trifluridine
* Trifluridine- fluorinated pyrimidine
o inhibits viral DNA synthesis same as acyclovir
o incorporates into viral and cellular DNA
o Uses: HSV-1 and HSV-2 (topically)
Vidarabine
* An adenosine analog
* inhibits viral DNA polymerase
* incorporated into viral and cellular DNA
* metabolized to hypoxanthine arabinoside
* Side Effects: GI intolerance and myelosuppression

Anti-Cytomegalovirus Agents
* Gancyclovir
* Valgancyclovir
* Cidofovir
* Foscarnet
* Fomivirsen

Ganciclovir
* An acyclic guanosine analog
* requires triphosphorylation for activation
* monophosphorylation is catalyzed by a phosphotransferase in CMV and by thymidine kinase in HSV cells
* M.O.A.: same as acyclovir
* Uses: CMV*, HSV, VZV,and EBV
* Side Effect: myelosuppression

Valgancyclovir
* Monovalyl ester prodrug of gancyclovir
* Metabolized by intestinal and hepatic esterases when administered orally
* M.O.A.: same as gancyclovir
* Uses: CMV*
* Side Effect: myelosuppression

Cidofovir
* A cytosine analog
* phosphorylation not dependent on viral enzymes
* Uses: CMV*, HSV-1, HSV-2, VZV, EBV, HHV-6, adenovirus, and human papillomavirus
* Side Effects: nephrotoxicity (prevented by admin. of probenecid)
* Resistance: mutation in DNA polymerase gene

Foscarnet
* An inorganic pyrophosphate
* inhibits viral DNA polymerase, RNA polymerase, and HIV reverse transcriptase
* does not have to be phosphorylated
* Uses: HSV, VZV, CMV, EBV, HHV-6, HBV, and HIV
* Resistance due to mutations in DNA polymerase gene
* Side Effects: hypo- or hypercalcemia and phosphotemia

Fomivirsen
* An oligonucleotide
* M.O.A.: binds to mRNA and inhibits protein synthesis and viral replication
* Uses: CMV retinitis
* Side effects: iritis and increased intraocular pressure

Antiretroviral Agents
1) Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
2) Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)
3)Protease inhibitors

Reverse Transcriptase Inhibitors
* Zidovudine (AZT)
* Didanosine- causes pancreatitis*
* Lamivudine- causes pancreatitis
* Zalcitabine- causes peripheral neuropathy*
* Stavudine- causes peripheral neuropathy*
* Abacavir

Mechanism of Action Zidovudine (AZT)
* A deoxythymidine analog
* enters the cell via passive diffusion
* must be converted to the triphosphate form by mammalian thymidine kinase
* competitively inhibits deoxythymidine triphosphate for the reverse transcriptase enzyme
* causes chain termination

Mechanism of Resistance Zidovudine
* Due to mutations in the reverse transcriptase gene
* more frequent after prolong therapy and in persons with HIV

Clinical Uses Zidovudine
* Available in IV and oral formulations
* activity against HIV-1, HIV-2, and human T cell lymphotropic viruses
* mainly used for treatment of HIV, decreases rate of progression and prolongs survival
* prevents mother to newborn transmission of HIV

Side Effects Zidovudine
* Myelosuppression, including anemia and neutropenia
* GI intolerance, headaches, and insomnia

Other NRTIs
* Didanosine- synthetic deoxy-adenosine analog; causes pancreatitis*
* Lamivudine- cytosine analog
* Zalcitabine- cytosine analog; causes peripheral neuropathy*
* Stavudine- thymidine analog;causes peripheral neuropathy*
* Abacavir- guanosine analog; more effective than the other agents; fatal hypersensitivity reactions can occur


Nucleotide Inhibitors
* Tenofovir
* Adefovir

Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)
* Nevirapine
* Delavirdine
* Efavirenz
Mechanism of Action NNRTIs
Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Protease Inhibitors
Indinavir and Ritonavir
Saquinavir
Nelfinavir and Amprenavir
Fusion Inhibitors
Anti-Hepatitis Agents
Interferons
Ribavirin
Anti-Influenza Agents
Amantadine and Rimantadine
Zanamivir and Oseltamivir
Antifungal Agents
Fungal Infections
Systemic Antifungals
Amphotericin B
Flucytosine
Azoles
Differences in Azoles
Mucocutaneous Antifungals
Topical Antifungals

Antiviral Agents.ppt

Read more...
All links posted here are collected from various websites. No video or powerpoint files are uploaded on this blog. If you are the original author and do not wish to display your content on this blog please Email me anandkumarreddy at gmail dot com I will remove it. The contents of this blog are meant for educational purpose and not for commercial use. If you use any content give due credit to the original author.

This site uses cookies from Google to deliver its services, to personalise ads and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies.

  © Blogger templates Newspaper III by Ourblogtemplates.com 2008

Back to TOP